-
Study aim
-
The study evaluated the efficacy of an Ayurvedic medicine regimen in managing symptoms of vaginal discomfort among women
-
Design
-
Pragmatic, community based, parallel group, single blinded, randomized controlled trial. Total 65 patients will be enrolled. Patients who met our inclusion criteria will be randomized into three groups.
-
Settings and conduct
-
At Noreen Nishat Welfare Hospital ,Khanewal ,Pakistan after approval for the study design granted by the Review Board and the Ethical Committee of Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
-
Participants/Inclusion and exclusion criteria
-
Females of aged 16-55 years, with symptoms of abnormal vaginal discharge, excessive vaginal irritation, and itching, will be chosen for the study. Strict exclusions included pregnant women (due to altered vaginal flora and fetal safety concerns), those with prolapsed uterus (potential impact on symptoms), history of malignancy (to avoid treatment-related complications), severe illnesses (to maintain study integrity), and individuals with known allergies (to prevent confounding reactions)
-
Intervention groups
-
Participants will be assigned to three groups: Positive Control (G1) will receive oral Metro gel (metronidazole, 5 grams/day for 5 days), Negative Control (G2) will receive no allopathic medicine (distilled water), and Experimental Group (G3) will recieve daily ayurvedic medicine (10 grams/day for 30 days)
-
Main outcome variables
-
Primary symptoms will be assessed included excessive vaginal discharge, itching, swelling, redness, and unpleasant odor. Secondary symptoms evaluated will be back pain, constipation, loss of appetite, painful intercourse, and general well-being.